Correction: Major shareholders, members of the board of directors and members of the executive management intend to exercise their warrants of series TO 7 in Smoltek

This press release is an English version of the previously published Swedish version, which has interpretive precedence.

Correction: In the press release we published at 10:15 a.m. today, June 14, 2023, there was an error in the table and in the preamble. It is now corrected.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, BELARUS, JAPAN, NEW ZEALAND, RUSSIA, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, SINGAPORE, CANADA OR ANY OTHER JURISDICTION WHERE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE FURTHER ACTION THAN WHAT IS REQUIRED UNDER SWEDISH LAW.

Smoltek Nanotech Holding AB (publ) ("Smoltek" or the “Company") hereby announces that major shareholders in the Company, and members of the Company’s board of directors and management that holds warrants of series TO 7, has informed the Company that they intend to exercise their warrants for subscription of new shares in the Company. This corresponds to an investment of approximately SEK 579 thousand, corresponding to approximately 6.6 percent of the total amount of outstanding warrants of series TO 7. The exercise period for the warrants of series TO 7 is currently ongoing and will continue until and including June 19, 2023.

Smoltek has received non-binding commitments that the following holders of warrants of series TO 7 intends to exercise their warrants for subscription of new shares in the Company:

Summarized terms for the warrants of series TO 7

Exercise period: June 5, 2023 – June 19, 2023 
Exercise price: SEK 3.56 per share 
Issue size: 2,452,996 warrants of series TO 7 entitle the holder to subscribe for 2,452,996 new shares. Upon full exercise, the Company will receive approximately SEK 8.7 million, before issuance costs. 
Last day for trading warrants of series TO 7: June 15, 2023

Share capital, shares and dilution 
Upon full exercise of all warrants of series TO 7, the share capital will increase by SEK 292,221.126758, from SEK 1,690,297.312587 to SEK 1,982,518.439345, and the number of shares will increase by 2,452,996 shares, from 14,188,887 shares to 16,641,883 shares. The dilution upon full exercise of all warrants of series TO 7 amounts to approximately 14.74 percent of the total number of shares and votes in the Company.

Please note that warrants of series TO 7 that are not exercised by June 19, 2023, or sold by June 15, 2023, will expire worthless. In order to prevent the warrants of series TO 7 from expiring worthless, they need to be actively exercised for subscription of new shares in the Company or sold. Please be aware that some custodians may close the subscription opportunity earlier than June 19, 2023. Holders of warrants of series TO 7 through custodians are therefore advised to contact their custodian early during the exercise period to obtain information on subscription and payment.

How warrants are exercised for subscription of new shares in the Company

Nominee-registered warrants (Custody account): Subscription and payment by exercise of warrants of series TO 7 shall be made in accordance with instructions from each nominee. Please contact your nominee for additional information.

Direct-registered warrants (Securities account): No accounts for issuing nor any instructions regarding payments will be sent out. Subscriptions will be made through simultaneous payment in accordance with the instructions on the application form. The warrants of series TO 7 will then be replaced by interim shares awaiting registration at the Swedish Companies Registration Office.

Advisers 
Mangold Fondkommission AB is financial adviser and MAQS Advokatbyrå AB is legal adviser for the Company in connection with the subscription of the warrants of series TO 7.

For further information: 
Håkan Persson, CEO of Smoltek Nanotech Holding AB
E-mail: hakan.persson@smoltek.com  
Phone: +46 731 03 05  
Website: www.smoltek.com/investors   

About Smoltek  
Smoltek is a Swedish technology company based in Gothenburg, specialized in the development and integration of carbon nanotechnology. The technology is used in the manufacture of vertical carbon nanostructures to create a three-dimensional surface in precision-defined patterns to solve advanced materials engineering problems in the process and semiconductor industry. Today, we focus on capturing the potential of the digital mobile phone revolution and the development of green energy production, which has resulted in the Company's two different business areas: semiconductors and hydrogen. In the semiconductor business area, the Company obtains ultra-thin capacitors intended for decoupling capacitors for application processes in mobile phones, and in the hydrogen business area, the first product is planned to be a highly efficient cell material intended for use in PEM electrolysers to drastically reduce investment cost to produce fossil-free hydrogen. Smoltek's technology makes components and materials thinner, more energy efficient, more powerful, and cheaper. This is made possible by the three-dimensional surface structure of the carbon nanostructures, which creates a surface that can be refined multiple times in the same volume for, for example, electrical and chemical processes. Smoltek has a strongly patent-protected technology consisting of roughly 110 patent assets within 20 patent families, of which 78 are currently granted patents. The Company's stock is listed on the Spotlight Stock Market. For more information, go to www.smoltek.com/investors.

Important information 
Publication, disclosure, or distribution of this press release may in certain jurisdictions be subject to restrictions by law, and persons in jurisdictions where this press release has been published or distributed should inform themselves about and comply with such legal restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with applicable rules in their respective jurisdiction. This press release does not constitute an offer to acquire or subscribe for any securities in Smoltek in any jurisdiction, neither from Smoltek nor from any other party.

This press release does not constitute an offer or invitation to acquire or subscribe for securities in the United States. The securities mentioned herein may not be sold in the United States without registration or without the application of an exemption from registration under the U.S. Securities Act of 1933 ("Securities Act"), and may not be offered or sold in the United States unless they are registered, exempt from, or in a transaction not subject to the registration requirements under the Securities Act. There is no intention to register any securities mentioned herein in the United States or to make a public offer regarding such securities in the United States. The information in this press release may not be disclosed, published, copied, reproduced, or distributed, directly or indirectly, in whole or in part, in or into Australia, Hong Kong, Japan, Canada, New Zealand, Switzerland, South Africa, the United States, Belarus, Russia, or any other jurisdiction where such disclosure, publication, or distribution of this information would contravene applicable regulations or where such action is subject to legal restrictions or would require additional registration or other measures beyond what is required under Swedish law. Actions in violation of this instruction may constitute a breach of applicable securities laws.